Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
Arkema France S.A. has filed an appeal against the European Chemicals Agency (ECHA) regarding a follow-up decision on the company's compliance with a previous ECHA directive. The contested decision, issued on January 5, 2024, faults Arkema for partial non-compliance in conducting an extended one-generation reproductive toxicity study (EOGRTS) as required by ECHA's initial compliance check. Arkema disputes the decision on multiple legal grounds, including exceeding time limits, breaching legal principles, and faulty scientific assessment, and seeks annulment of the decision along with a refund of the appeal fee. This ongoing legal battle underscores the challenges and complexities of regulatory compliance within the EU chemicals regulation framework.
MORE INFO ON: echa.europa.eu
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions